PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
13-Dec-2022 Global Drug Bioavailability Enhancement Summit 2023: Formulation and Delivery Technologies for Improving Drug Product Performance and Bioavailability (Princeton, NJ, United States - May 16-17, 2023) - ResearchAndMarkets.com Businesswire
13-Dec-2022 MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program Businesswire
13-Dec-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
13-Dec-2022 Advicenne Obtains Orphan Drug Designation for ADV7103 in the United States for the Treatment of Distal Renal Tubular Acidosis (dRTA) Businesswire
13-Dec-2022 Agilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung Cancer Businesswire
13-Dec-2022 JT Included in the Dow Jones Sustainability Asia Pacific Index for the Ninth Consecutive Year Businesswire
13-Dec-2022 Kessler Topaz Meltzer & Check, LLP Announces the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Twist Bioscience Corporation Businesswire
13-Dec-2022 GI CELL Enters Agreement with Optieum Biotechnologies Businesswire
13-Dec-2022 Rapid Dose Therapeutics Provides Update on Failure to File Cease Trade Order Businesswire
13-Dec-2022 Aptar Announces the Realignment of Two of its Business Reporting Segments Businesswire
12-Dec-2022 DeciBio Consulting Adds Steve Beuchaw as a Partner, Establishing a New York Presence Businesswire
12-Dec-2022 The Worldwide Industrial Workwear Industry is Expected to Reach $51 Billion by 2027 - ResearchAndMarkets.com Businesswire
12-Dec-2022 Global Rare Disease Drugs Market Report 2022: A $147.12 Billion Market in 2021 - Analysis By Drug Type, Therapeutic Area, Patients, Route of Administration, Distribution Channel - ResearchAndMarkets.com Businesswire
12-Dec-2022 Prothena Presents Data Demonstrating Consistent Survival Benefit Observed with Birtamimab in Mayo Stage IV AL Amyloidosis Patients in Phase 3 VITAL Study at ASH 2022 Businesswire
12-Dec-2022 Genentech Presents New Data Demonstrating the Potential of Glofitamab and Mosunetuzumab as Fixed-Duration, Off-The-Shelf Treatment Options for Lymphoma Businesswire
12-Dec-2022 Orca Bio Presents Encouraging Interim Clinical Data on Orca-Q in Haploidentical Allogeneic Hematopoietic Stem Cell Transplants at 64th ASH Annual Meeting Businesswire
12-Dec-2022 Gilead Sciences Again Named to Dow Jones Sustainability World Index Businesswire
12-Dec-2022 Global Medical Tubing Market Report 2022 to 2030 - Featuring Avient, Saint-Gobain, Hitachi and Microlumen Among Others - ResearchAndMarkets.com Businesswire
12-Dec-2022 Global Epilepsy Drug Market (2022-2027): Rising Drug Approvals of Anticonvulsant Drugs from Regulatory Bodies Presents Opportunities - ResearchAndMarkets.com Businesswire
12-Dec-2022 Asher Bio Presents New Preclinical Data at ASH Applying Cis-Targeted Cytokines to Enhance CAR-T Cell Therapies Businesswire